Publications 2023

Andersen IM, Reims HM, Grzyb K, Fevang B, Melum E, Aukrust P, Wiencke K, Nordøy I, Line PD, Jørgensen SF (2023)
Long-term survival after liver transplantation in patients with common variable immunodeficiency
Liver Transpl, 29 (8), 894-899
DOI 10.1097/LVT.0000000000000130, PubMed 36932715

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 8 (1), 4
DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Publications 2022

Bergquist A, Weismüller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, Lytvyak E, Wunsch E, Milkiewicz P, Zenouzi R, Schramm C, Cazzagon N, Floreani A, Liby IF, Wiestler M, Wedemeyer H, Zhou T, Strassburg CP, Rigopoulou E, Dalekos G, Narasimman M, Verhelst X, Degroote H, Vesterhus M et al. (2022)
Impact on follow-up strategies in patients with primary sclerosing cholangitis
Liver Int, 43 (1), 127-138
DOI 10.1111/liv.15286, PubMed 35535655

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 7 (1), 174
DOI 10.1038/s41541-022-00586-7, PubMed 36585405

Publications 2021

Fossdal G, Mjelle AB, Wiencke K, Bjørk I, Gilja OH, Folseraas T, Karlsen TH, Rosenberg W, Giil LM, Vesterhus M (2021)
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
JHEP Rep, 3 (5), 100328
DOI 10.1016/j.jhepr.2021.100328, PubMed 34485881

Vesterhus M, Wiencke K, Haukeland JW, Frigstad SO, Karlsen LN, Jørgensen KK, Folseraas T (2021)
[Diagnosis and treatment of autoimmune hepatitis]
Tidsskr Nor Laegeforen, 141 (10)
DOI 10.4045/tidsskr.20.1045, PubMed 34182737

Publications 2016

Eskeland SL, Brunborg C, Seip B, Wiencke K, Hovde Ø, Owen T, Skogestad E, Huppertz-Hauss G, Halvorsen FA, Garborg K, Aabakken L, de Lange T (2016)
First quality score for referral letters in gastroenterology-a validation study
BMJ Open, 6 (10), e012835
DOI 10.1136/bmjopen-2016-012835, PubMed 27855107

Publications 2013

Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
[Investigation of anemia]
Tidsskr Nor Laegeforen, 133 (6), 610
DOI 10.4045/tidsskr.13.0256, PubMed 23552139

Publications 2011

Wiencke K, Boberg KM (2011)
Current consensus on the management of primary sclerosing cholangitis
Clin Res Hepatol Gastroenterol, 35 (12), 786-91
DOI 10.1016/j.clinre.2011.04.007, PubMed 21963085

Publications 2007

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A (2007)
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
Tissue Antigens, 69 (2), 161-9
DOI 10.1111/j.1399-0039.2006.00738.x, PubMed 17257319

Publications 2006

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM (2006)
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis
Am J Gastroenterol, 102 (1), 115-21
DOI 10.1111/j.1572-0241.2006.00928.x, PubMed 17100974

Wiencke K (2006)
Genetic studies in primary sclerosing cholangitis
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 442, 1 b. (flere pag.)
BIBSYS 061913405

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
Scand J Gastroenterol, 41 (5), 586-91
DOI 10.1080/00365520500377870, PubMed 16638702

Publications 2005

Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
J Neuroimmunol, 166 (1-2), 197-201
DOI 10.1016/j.jneuroim.2005.06.002, PubMed 16005527

Publications 2004

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN Study Group (2004)
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J Hepatol, 41 (2), 209-14
DOI 10.1016/j.jhep.2004.04.024, PubMed 15288468

Publications 2003

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508

Etokebe GE, Wiencke K, Haug T, Spurkland A (2003)
The use of modified primer competitors to enhance yields and specificity of HLA class I amplification by polymerase chain reaction (PCR)
Tissue Antigens, 61 (2), 172-6
DOI 10.1034/j.1399-0039.2003.00011.x, PubMed 12694586

Publications 2001

Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001)
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles
Hepatology, 34 (4 Pt 1), 625-30
DOI 10.1053/jhep.2001.27543, PubMed 11584356

Publications 1988

Wiencke K (1988)
Murin friend erythroleukemi virus infeksjon: en mulig modell for HIV/AIDS?
[K. Wiencke], [Trondheim], 64 s.
BIBSYS 885009770